Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus propofol versus propofol alone for ERCP sedation
ACTRN12612000964819Phase 4Recruiting
- Sponsor
- Dr Qianbo Chen
- Start
- Jun 2012
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial in biliary disease comparing Dexmedetomidine + propofol with Propofol (2 arms). Primary endpoint: Sedation level and demand for additional sedatives. Started Jun 2012; status: recruiting.
02
Drugs
dexmedetomidinepropofol
03
Conditions
biliary disease
Beyond the preview
Go deeper on ACTRN12612000964819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000964819.